EGFR and cancer: The elevated PI3K/AKT/p65 signaling pathway also up-regulated TGFα secretion in rCAFs to reduce cancer cell chemosensitivity via activation of the EGFR/Src/STAT3-driven survival pathway and repression of the p53/caspase-3-driven apoptosis.